Category Specific RSS

News

Emerge Gaming launches competitive gaming portal

Leading eSports and casual gaming tournament company Emerge Gaming Limited (ASX:EM1) have today announced their official launch of ArcadeX in…

7 years ago

Lightbox and Neon to merge, creating ‘supercharged’ streaming service for Kiwis

As video-on-demand (VOD) services continue emerging as the platform of preference amongst television viewers, New Zealand residents will soon have…

7 years ago

MGM secures major UK distributor for child-safe GPS smartphones

Tech company MGM Wireless (ASX: MWR) could soon be in line for a significant uptick in sales having entered into…

7 years ago

Researchers choose LumiGrow for horticulture studies, Enevis continues turnaround

Australian tech company Enevis (ASX: ENE) has continued an impressive business turnaround which has led to three leading Universities electing…

7 years ago

G Medical remote patient monitoring services sees 105% growth

Medtech innovator, G Medical Innovations (ASX: GMV), have experienced a significant boost in market confidence, following the news that the…

7 years ago

Holista files patent application for tech that makes CBD oil 40x more potent

Food technology company Holista Colltech (ASX: HCT) has filed a patent for platform technology claiming to deliver fat-soluble medications which…

7 years ago

Zoono secures Chinese distributor after impressive African swine fever trials

With China having lost more than 100 million pigs due to the recent outbreak of African swine fever in the…

7 years ago

Beam launches world-first global satellite SOS messaging service

Thousands of would-be deaths will soon be saved with Beam Communications (ASX: BCC) today launching presales of their satellite SOS…

7 years ago

Wattle Health sign 10-year agreement with Chemist Warehouse

Infant product manufacturer, Wattle Health Australia Limited (ASX: WHA), are set to significantly expand their domestic and international distribution channels,…

7 years ago

Encouraging data for Cynata aiming to treat condition responsible for half of hospital deaths

Australian biopharmaceuticals developer Cynata Therapeutics (ASX: CYP) has returned highly encouraging data from its preclinical trials for its Cymerus™ product…

7 years ago